N-Ethyltryptamine
Chemical compound
From Wikipedia, the free encyclopedia
N-Ethyltryptamine (NET), also abbreviated as NETP, is a tryptamine that is structurally related to N-methyltryptamine (NMT) and the psychedelic drugs N,N-dimethyltryptamine (DMT) and N,N-diethyltryptamine (DET).[1]
- None
 | |
 | |
| Clinical data | |
|---|---|
| Other names | NET; NETP; Ethyltryptamine |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H16N2 |
| Molar mass | 188.274 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 87 to 88 °C (189 to 190 °F) |
| |
| |
| (verify) | |
Use and effects
Alexander Shulgin included NET as an entry in his book TiHKAL (Tryptamines I Have Known and Loved).[1] However, he stated that it had been subjected only to modest human trials and that no active dose level had been identified.[1]
Pharmacology
Pharmacodynamics
NET has been found to act as a potent serotonin 5-HT2A receptor full agonist and a selective serotonin releasing agent.[2] It is inactive at the 5-HT1A receptor.[2]
Chemistry
Synthesis
The chemical synthesis of NET has been described.[1]
Analogues
Analogues of NET include N-methyltryptamine (NMT), dimethyltryptamine (DMT), methylethyltryptamine (MET), and diethyltryptamine (DET), among others.[1]
Society and culture
Legal status
Canada
NET is not a controlled substance in Canada as of 2025.[3]